Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole efficacy and safety in Restless Legs Syndrome
NCT00329602Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 4 trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00329602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329602.